Prospective study of safety, immunogenicity, and efficacy of inactivated COVID-19 vaccine in tuberous sclerosis complex children on sirolimus

While sirolimus is widely used in tuberous sclerosis complex (TSC), its impact on coronavirus disease 2019 (COVID-19) vaccination remains unclear. To evaluate the safety, immunogenicity, and efficacy of inactivated COVID-19 vaccine on the children with TSC on sirolimus, we conducted a prospective co...

Full description

Bibliographic Details
Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Sufang Lin, Xia Zhao, Lin Li, Qiru Su, Weiwei Long, Xiaoqin Tian, Jinghua Ye, Bixia Yuan, Yan Hu, Jianxiang Liao, Hongbing Zhang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Subjects:	COVID-19 vaccine immunogenicity efficacy tuberous sclerosis complex sirolimus
Online Access:	https://www.tandfonline.com/doi/10.1080/21645515.2025.2535120

Similar Items

Effectiveness and safety of topical sirolimus in children with angiofibromas and tuberous sclerosis complex
by: Andrea Fernández de Lara-Arrieta, et al.
Published: (2025-04-01)

Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results
by: Jamie K. Capal, et al.
Published: (2024-06-01)

Therapeutic effect of Topical Sirolimus on Facial Angiofibromas in Patients of Tuberous Sclerosis Complex
by: Leena HN, et al.
Published: (2024-04-01)

Initial Dosage Recommendation for Sirolimus in Children With Tuberous Sclerosis Complex
by: Dong-Dong Wang, et al.
Published: (2020-06-01)

Tuberous sclerosis complex: review based on new diagnostic criteria
by: Larissa Karine Leite Portocarrero, et al.
Published: (2018-06-01)

Prenatal Diagnosis and Management of Tuberous Sclerosis Complex with Cardiac Rhabdomyoma: A Case Report Highlighting the Role of Sirolimus and Postnatal Complications
by: David Asael Rodríguez-Torres, et al.
Published: (2025-07-01)

Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex
by: Tohru Okanishi, et al.
Published: (2020-01-01)

Antiepileptic Effect and Safety Profile of Rapamycin in Pediatric Patients With Tuberous Sclerosis Complex
by: Krzysztof Sadowski, et al.
Published: (2022-04-01)

Nested Case-Control Study of Intervention in Early Infancy to Prevent Tuberous Sclerosis Complex–Associated Renal Angiomyolipoma
by: Shuo Dun, et al.
Published: (2025-06-01)

Long-term safety and influence on growth in patients receiving sirolimus: a pooled analysis
by: Yang-Yang Wang, et al.
Published: (2024-08-01)

Successful Prenatal Treatment of Cardiac Rhabdomyoma in a Fetus with Tuberous Sclerosis
by: Joachim Carsten Will, et al.
Published: (2023-03-01)

The Therapeutic Potential of Oral Everolimus for Facial Angiofibromas in Pediatric Tuberous Sclerosis Complex: A Case-Based Analysis of Efficacy
by: George Imataka, et al.
Published: (2024-12-01)

Safety and Immunogenicity of Vaccines in Children with Kaposiform Hemangioendothelioma Receiving Sirolimus: A Prospective Study
by: Junhong Yuan, et al.
Published: (2025-08-01)

Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice
by: Ine Cockerell, et al.
Published: (2023-12-01)

Revised Diagnostic Criteria of Tuberous Sclerosis
by: J Gordon Millichap
Published: (2000-05-01)

Tuberous Sclerosis
by: J Gordon Millichap
Published: (1988-01-01)

Bourneville tuberous sclerosis - a case report
by: Mihaela Lungu, et al.
Published: (2013-03-01)

An interesting case of Tuberous sclerosis
by: A Roy, et al.
Published: (2015-07-01)

Progress in the Treatment of Topical Rapamycin Preparations
by: WANG Senfen, et al.
Published: (2023-04-01)

Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysis
by: Yu-Ting Lin, et al.
Published: (2022-03-01)

EEG and MRI in Identifying Tuberous Sclerosis Lesions for Epilepsy Surgery
by: J Gordon Millichap
Published: (2005-06-01)

Tuberous Sclerosis
by: Praveen Kumar Panwar, et al.
Published: (2014-01-01)

Cognitive Impairment in Tuberous Sclerosis Complex
by: J Gordon Millichap
Published: (2008-04-01)

GELASTIC SEIZURES IN TUBEROUS SCLEROSIS
by: M. B. Mironov, et al.
Published: (2015-04-01)

Tuberous Sclerosis and Neonatal Astrocytoma
by: J Gordon Millichap
Published: (1991-02-01)

Tuberous Sclerosis: Diagnostic Criteria
by: J Gordon Millichap
Published: (1992-06-01)

Transplacental sirolimus: a new treatment strategy for life-threatening fetal cardiac rhabdomyomas—a case report
by: Kaname Uno, et al.
Published: (2025-06-01)

A dermatological assessment of pediatric patients with tuberous sclerosis complex (TSC)
by: Beatriz Azevedo Nunes, et al.
Published: (2024-09-01)

Autism and ADHD in Tuberous Sclerosis
by: J Gordon Millichap
Published: (1994-02-01)

Seizures and IQ in Tuberous Sclerosis
by: J Gordon Millichap
Published: (1992-11-01)

Visual Loss in Tuberous Sclerosis
by: J Gordon Millichap
Published: (1992-01-01)

Tuberous Sclerosis and Infantile Spasms
by: J Gordon Millichap
Published: (1990-04-01)

Epilepsy Surgery and Tuberous Sclerosis
by: J Gordon Millichap
Published: (1993-09-01)

MRI and EEG in Tuberous Sclerosis
by: J Gordon Millichap
Published: (1991-01-01)

Tuberous Sclerosis and Infantile Spasms
by: J Gordon Millichap
Published: (1987-06-01)

Mosaicism in Tuberous Sclerosis Complex
by: J Gordon Millichap
Published: (1999-07-01)

Deciduous Teeth in Tuberous Sclerosis
by: J Gordon Millichap
Published: (1996-10-01)

Case report on tuberous sclerosis
by: Nadezhda V. Krasnova, et al.
Published: (2021-04-01)

Predictive Power of EEG in Infants with Tuberous Sclerosis
by: Molly Tracy
Published: (2016-04-01)

Case Report: Tuberous sclerosis complex-associated hemihypertrophy successfully treated with mTOR inhibitor sirolimus
by: Konomi Shimoda, et al.
Published: (2024-02-01)